3.55
0.02 (0.57%)
0.02 (0.57%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.02 | 0.57% | 3.55 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.5433 | 3.48 | 3.58 | 3.49 | 3.53 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.55 | 3.58 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,509 | 1,014,837 | $ 3.52 | $ 3,577,299 | 2,011,471 | 2.55 - 5.2997 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:37 | formt | 100 | $ 3.55 | USD |
Catalyst Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 367.95M | 103.65M | 96.38M | $ 102.31M | $ 73.82M | 0.29 | 5.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 86.75k | 9.00% |
Catalyst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.57 | 3.665 | 3.40 | 3.51 | 1,695,066 | -0.02 | -0.56% |
| 1 Month | 3.71 | 3.72 | 3.30 | 3.49 | 2,063,017 | -0.16 | -4.31% |
| 3 Months | 3.21 | 3.99 | 2.875 | 3.46 | 1,699,792 | 0.34 | 10.59% |
| 6 Months | 5.04 | 5.15 | 2.875 | 3.52 | 1,785,383 | -1.49 | -29.56% |
| 1 Year | 4.36 | 5.2997 | 2.55 | 3.92 | 1,848,283 | -0.81 | -18.58% |
| 3 Years | 3.93 | 7.67 | 1.85 | 3.96 | 1,672,829 | -0.38 | -9.67% |
| 5 Years | 2.07 | 7.67 | 0.51 | 3.39 | 1,378,037 | 1.48 | 71.5% |
Catalyst Pharmaceuticals Description
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome. |
